These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 209368)

  • 1. [Digital arteriopathies of the hand].
    Pedrini L; Stella A
    Minerva Cardioangiol; 1978 May; 26(5):343-60. PubMed ID: 209368
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of ischemia of the hand and fingers.
    Dale WA; Lewis MR
    Surgery; 1970 Jan; 67(1):62-79. PubMed ID: 5409864
    [No Abstract]   [Full Text] [Related]  

  • 3. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 4. [Digital arteriopathies of the arms and their treatment by posterior spinal cord neurostimulation].
    Vinckier L; Hatron PY; Lefebvre JM
    J Mal Vasc; 1992; 17(2):138-40. PubMed ID: 1613404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden deafness and its several treatments.
    Saunders WH
    Laryngoscope; 1972 Jul; 82(7):1206-13. PubMed ID: 4342769
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of sympathectomy in digital artery disease.
    Birnstingl M
    Br Med J; 1967 Jun; 2(5552):601-5. PubMed ID: 6025596
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetranicotinoylfructose in disorders of digital blood flow.
    Holti G; Newell DJ; Poole HG
    Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical course following upper thoracic sympathectomy in digital arterial occlusive diseases].
    Mahler F; Schlumpf M; Brunner U
    Vasa; 1977; 6(2):186-9. PubMed ID: 868223
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases].
    Chiti E
    Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peripheral blood flow velocity in arterial occlusive disease during i.v. long term therapy with vasoactive agents. Plethysmographic comparative study].
    Heidrich H; Witt D; Witt E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1750-2. PubMed ID: 347800
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C
    Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 14. Some aspects of the treatment of vascular diseases.
    Matts SG
    Br J Clin Pract; 1974 Jan; 28(1):33-6. PubMed ID: 4814024
    [No Abstract]   [Full Text] [Related]  

  • 15. Ischemia of the hand in systemic disease. The potential role of microsurgical revascularization and digital sympathectomy.
    Jones NF
    Clin Plast Surg; 1989 Jul; 16(3):547-56. PubMed ID: 2673634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to the treatment of ischemic conditions of the extremities: continous intraarterial infusion therapy.
    Skalkeas G; Balas P; Katsogianis A; Bakoulas G; Karagianakos R
    Angiology; 1969 Mar; 20(3):144-54. PubMed ID: 5773966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasodilator treatment in sudden deafness].
    Blaettler WH
    Rev Med Suisse Romande; 1973 Oct; 93(10):753-6. PubMed ID: 4757065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
    Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.